worldwid
outbreak
coronaviru
diseas
demonstr
part
small
world
diffus
contagi
diseas
inevit
although
new
coronaviru
origin
wuhan
seem
present
lower
lethal
compar
previou
epidem
outbreak
coronavirus
capac
diffus
phenomen
one
infect
individu
may
transmit
viru
other
note
screen
base
symptom
sign
ineffect
asymptomat
person
spread
diseas
earli
phase
wide
diffus
viru
call
action
publish
lancet
respiratori
medicin
underlin
need
alert
zoonot
viru
infect
cross
speci
infect
human
popul
particular
recommend
made
prepar
intens
care
team
deliv
extracorpor
organ
support
eco
therapi
infect
patient
whose
pulmonari
syndrom
particularli
sever
despit
previou
experi
present
higher
incid
sever
complic
lethal
current
outbreak
still
requir
intens
care
infect
popul
among
critic
ill
patient
mortal
rate
even
specif
tropism
airway
epitheli
cell
infect
seem
weak
human
transmiss
like
occur
lower
respiratori
tract
diseas
develop
caus
mild
flulik
symptom
even
symptom
major
patient
coronavirus
bind
receptor
angiotensinconvert
enzym
angiotensinconvert
enzym
present
epithelia
lung
small
intestin
colon
biliari
tract
fact
viral
nucleic
acid
found
stool
anal
swab
patient
diagnos
infect
cohort
patient
singapor
half
patient
test
viru
detect
stool
might
explain
liver
dysfunct
diarrhea
nausea
vomit
occur
patient
pneumonia
name
gutlung
crosstalk
chines
group
patient
pneumonia
caus
admit
intens
care
unit
icu
acut
respiratori
distress
syndrom
die
major
prevent
measur
undertaken
specif
area
incid
significantli
higher
limit
diffus
viru
despit
measur
requir
icu
servic
station
still
dramat
increas
person
commun
earli
report
mostli
come
china
suggest
sever
ill
patient
may
present
addit
organ
dysfunct
syndrom
least
part
relat
sepsislik
syndrom
induc
high
level
circul
cytokin
circumst
pulmonari
articl
licens
creativ
common
attributionnoncommercialnoderiv
intern
licens
cc
byncnd
http
wwwkargercomservicesopenaccesslicens
usag
distribut
commerci
purpos
well
distribut
modifi
materi
requir
written
permiss
exchang
compromis
domin
clinic
scenario
acut
kidney
injuri
heart
liver
dysfunct
may
also
becom
evid
cytokin
storm
may
induc
superimpos
septic
syndrom
direct
effect
viru
infect
host
past
experi
matur
influenza
sar
mer
suggest
sever
ill
depend
comorbid
immunecompet
individu
sever
situat
howev
uncontrol
inflammatori
state
subsequentsimultan
immuneparalysi
direct
consequ
endocrin
effect
proand
antiinflammatori
cytokin
spill
system
circul
special
interest
retrospect
analysi
german
cohort
critic
ill
patient
preval
virusassoci
hemophagocyt
syndrom
vah
patient
syndrom
receiv
extracorpor
membran
oxygen
ecmo
ecmo
could
trigger
amplifi
cytokin
activ
pathogenesi
vah
involv
excess
product
interferon
gamma
vah
prototyp
cytokin
storm
syndrom
present
experi
san
bortolo
hospit
critic
ill
patient
hyperferritinemia
rais
awar
vah
differenti
diagnosi
organ
dysfunct
syndrom
pharmacolog
treatment
simpli
avail
efficaci
mechan
ventil
hemodynam
support
seem
possibl
therapeut
strategi
howev
extracorpor
therapi
hemofiltr
hemoperfus
hp
offer
new
possibl
support
differ
organ
multipl
organ
dysfunct
condit
use
specif
extracorpor
circuit
devic
heart
lung
kidney
liver
partial
replac
least
sustain
sever
phase
syndrom
concept
known
eco
import
techniqu
case
ecmo
mostli
appli
venoven
mode
furthermor
extracorpor
co
remov
anoth
option
perform
less
sever
case
facilit
less
invas
traumat
mechan
ventil
although
acut
kidney
injuri
patient
common
continu
renal
replac
therapi
may
offer
condit
mild
sever
kidney
dysfunct
signific
support
solut
fluid
control
true
left
ventricular
assist
devic
case
refractori
heart
failur
albumin
dialysi
hp
case
liver
dysfunct
hyperbilirubinemia
howev
accord
inform
collect
chines
colleagu
face
larg
proport
patient
complic
syndrom
icu
signific
benefit
seem
obtain
use
direct
hp
cartridg
contain
highli
biocompat
sorbent
micropor
resin
therapi
design
remov
excess
circul
cytokin
seem
display
remark
benefit
term
hemodynam
support
organ
function
recoveri
suggest
scheme
applic
cartridg
jafron
biomed
co
china
unit
util
h
first
h
unit
per
day
util
h
follow
day
europ
matur
experi
use
cytosorb
cartridg
cytosorb
corpor
nj
usa
exactli
purpos
control
deadli
inflamm
critic
ill
cardiac
surgeri
patient
approach
may
one
mani
other
util
extracorpor
therapi
sever
syndrom
requir
scientif
valid
emerg
current
epidem
suggest
mechan
nonspecif
remov
peak
circul
cytokin
proand
antiinflammatori
side
consist
peak
concentr
hypothesi
suggest
time
ago
presenc
inabl
obtain
instantan
monitor
biolog
level
cytokin
reason
approach
promot
nonspecif
remov
assum
cytokin
highest
concentr
remov
higher
amount
fig
would
facilit
return
less
sever
derang
immun
system
improv
level
immunolog
respons
host
concept
express
cytokinet
model
theori
reduct
circul
level
cytokin
may
allow
immun
system
patient
redirect
immunocompet
cell
sourc
site
inflamm
warn
user
techniqu
togeth
remov
cytokin
drug
antibiot
like
vancomycin
also
remov
vitro
model
prove
case
specif
adjust
antibiot
dosag
patient
bacteri
infect
care
plan
anoth
adjunct
potenti
extracorpor
therapi
lectin
affin
plasmapheresi
coronaviru
trap
blood
run
plasma
filter
filter
plasma
contain
viral
copi
pass
matrix
lectin
high
affin
viral
envelop
lectin
likewis
viral
copi
captur
viremia
reduc
therapi
explor
valid
main
messag
present
editori
tri
convey
icu
staff
treat
physician
familiar
concept
extracorpor
therapi
repres
today
import
strategi
critic
ill
pacoronaviru
epidem
extracorpor
therapi
intens
care
blood
purif
doi
tient
multipl
organ
dysfunct
train
research
plan
develop
skill
knowledg
area
new
membran
separ
process
adsorpt
techniqu
appear
new
frontier
fight
socal
cytokin
storm
syndrom
need
increas
awar
basic
principl
studi
mechan
optim
prescript
deliveri
differ
techniqu
need
stimul
research
data
collect
creat
suffici
scientif
evid
need
prepar
uncertain
futur
frequenc
crise
probabl
increas
must
retool
new
strategi
new
therapi
among
new
eco
therapi
ancient
use
say
si
vi
pacem
para
bellum
want
peac
get
prepar
war
acknowledg
declar
author
conflict
interest
declar
fund
sourc
declar
author
contribut
equal
manuscript
approv
submiss
fig
viral
infect
percentag
patient
suffer
sever
pneumonia
patient
may
system
cytokin
releas
due
ill
mechan
ventilationassoci
lung
injuri
extracorpor
membran
oxygen
induc
endotheli
dysfunct
consequ
organ
failur
b
applic
hp
may
contribut
reduc
burden
cytokin
cut
peak
nonspecif
way
restor
least
part
immunehomeostasi
hemoperfus
combin
continu
renal
replac
therapi
hpcrrt
effect
amplifi
addit
task
organ
support
accomplish
tnf
tumor
necrosi
factor
il
interleukin
hp
hemoperfus
crrt
continu
renal
replac
therapi
ecmo
extracorpor
membran
oxygen
ronco
